WADA welcomes Putin’s statement urging Russia to heed demands of McLaren reportSport March 01, 21:27
Moldova’s president initiates process of national reconciliation over TransnistriaWorld March 01, 21:14
Russian Foreign Ministry: Any sanctions against Syria to weaken anti-terrorist frontRussian Politics & Diplomacy March 01, 21:05
Russia rejects Al Jazeera’s report on alleged cooperation with terrorists in AfghanistanRussian Politics & Diplomacy March 01, 20:04
Moldova’s government recalls ambassador to RussiaWorld March 01, 20:02
OSCE envoy says Contact Group discussed recognition of DPR, LPR documents by MoscowWorld March 01, 20:00
Russian senator believes European Parliament’s resolutions on Syria not to solve crisisRussian Politics & Diplomacy March 01, 18:56
Dire Straits Experience to kick off their 2017 world tour in RussiaSociety & Culture March 01, 18:48
Volkswagen to recall 42 Lamborghini cars in Russia due to flame outbreak possibilityBusiness & Economy March 01, 18:46
MOSCOW, November 21. /ITAR-TASS/. The Russian Health Ministry has expressed concern over a big number of pharmacies in Russia, which provokes price dumping policies and lowers pharmacy quality standards, Health Minister Veronika Skvortsova told the Presidium of the Russian government on Thursday.
The Russian pharmacy market has a huge number of economic entities running the production and distribution sectors. A total of 550 organizations and a thousand foreign pharmacies have licenses for medicine production and deliveries, Skvortsova said with reference to the Single License Register of the Russian Ministry of Industry and Trade.
In Russia, there is one pharmacy per every 1,450 people, in the United States - one pharmacy per every 4,500 people and in Germany - one pharmacy per 3,900 people, she said. There is a surplus number of pharmacies in Russia; the quality of pharmacy services is worsening; the share of pharmacies capable to produce medicines or which have the necessary conditions for the storage of medicines and narcotic-containing stuff has been declining, Skvortsova said.
Creation of vertically integrated structures and large pharmacy networks hinders the development of a competitive environment, provokes price dumping and creates problems for producers of medicines, Skvortsova said.